Thomas Bugge

Prof. Thomas Bugge


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2013 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
DMDaniel Hargbøl Madsen
Daniel Hargbøl Madsen
DLDaniel Leonard
Daniel Leonard
AMAndrius Masedunskas
Andrius Masedunskas
AMAmanda Moyer
Amanda Moyer
HJHenrik Jessen Jürgensen
Henrik Jessen Jürgensen
TBThomas Bugge
Thomas Bugge
Tissue remodeling processes critically depend on the timely removal and remodeling of preexisting collagen scaffolds. Nevertheless, many aspects related to the turnover of this abundant extracellular matrix component in vivo are still incompletely understood. We therefore took advantage of recent advances in optical imaging to develop an assay to visualize collagen turnover in situ and identify cell types and molecules involved in this process. Collagen introduced into the dermis of mice underwent cellular endocytosis in a partially matrix metalloproteinase–dependent manner and was subsequently routed to lysosomes for complete degradation. Collagen uptake was predominantly executed by a quantitatively minor population of M2-like macrophages, whereas more abundant Col1a1-expressing fibroblasts and Cx3cr1-expressing macrophages internalized collagen at lower levels. Genetic ablation of the collagen receptors mannose receptor (Mrc1) and urokinase plasminogen activator receptor–associated protein (Endo180 and Mrc2) impaired this intracellular collagen degradation pathway. This study demonstrates the importance of receptor-mediated cellular uptake to collagen turnover in vivo and identifies a key role of M2-like macrophages in this process.

1 August 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
TBThomas Bugge
Thomas Bugge
TAToni M. Antalis
Toni M. Antalis
QWQingyu Wu
Qingyu Wu
Analysis of genome and expressed sequence tag data bases at the turn of the millennium unveiled a new protease family named the type II transmembrane serine proteases (TTSPs) in a Journal of Biological Chemistry minireview (Hooper, J. D., Clements, J. A., Quigley, J. P., and Antalis, T. M. (2001) J. Biol. Chem. 276, 857-860). Since then, the number of known TTSPs has more than doubled, and more importantly, our understanding of the physiological functions of individual TTSPs and their contribution to human disease has greatly increased. Progress has also been made in identifying molecular substrates and endogenous inhibitors. This minireview summarizes the current knowledge of the rapidly advancing TTSP field.

23 May 2002 in Oncogene
Verified
Journal Article
Closed access
KLKarin List
Karin List
CHChristian C Haudenschild
Christian C Haudenschild
RSRoman Szabo
Roman Szabo
WCWanJun Chen
WanJun Chen
SWSharon M Wahl
Sharon M Wahl
TBThomas Bugge
Thomas Bugge

15 August 2005 in Genes & Development
Verified
Journal Article
Open access
PDF file
KLKarin List
Karin List
RSRoman Szabo
Roman Szabo
AMAlfredo Molinolo
Alfredo Molinolo
VSVirote Sriuranpong
Virote Sriuranpong
VRVivien Redeye
Vivien Redeye
TBThomas Bugge
Thomas Bugge
Overexpression of the type II transmembrane serine protease matriptase is a highly consistent feature of human epithelial tumors. Here we show that matriptase possesses a strong oncogenic potential when unopposed by its endogenous inhibitor, HAI-1. Modest orthotopic overexpression of matriptase in the skin of transgenic mice caused spontaneous squamous cell carcinoma and dramatically potentiated carcinogen-induced tumor formation. Matriptase-induced malignant conversion was preceded by progressive interfollicular hyperplasia, dysplasia, follicular transdifferentiation, fibrosis, and dermal inflammation. Furthermore, matriptase induced activation of the pro-tumorigenic PI3K–Akt signaling pathway. This activation was frequently accompanied by H-ras or K-ras mutations in carcinogen-induced tumors, whereas matriptase-induced spontaneous carcinoma formation occurred independently of ras activation. Increasing epidermal HAI-1 expression completely negated the oncogenic effects of matriptase. The data implicate dysregulated matriptase expression in malignant epithelial transformation.

1 June 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TKTae Sung Kim
Tae Sung Kim
LSLakmali M. Silva
Lakmali M. Silva
VTVasileios Ionas Theofilou
Vasileios Ionas Theofilou
TGTeresa Greenwell-Wild
Teresa Greenwell-Wild
LLLu Li
Lu Li
NMNiki M. Moutsopoulos
Niki M. Moutsopoulos
Neutrophil infiltration is a hallmark of periodontitis, a prevalent oral inflammatory condition in which Th17-driven mucosal inflammation leads to destruction of tooth-supporting bone. Herein, we document that neutrophil extracellular traps (NETs) are early triggers of pathogenic inflammation in periodontitis. In an established animal model, we demonstrate that neutrophils infiltrate the gingival oral mucosa at early time points after disease induction and expel NETs to trigger mucosal inflammation and bone destruction in vivo. Investigating mechanisms by which NETs drive inflammatory bone loss, we find that extracellular histones, a major component of NETs, trigger upregulation of IL-17/Th17 responses, and bone destruction. Importantly, human findings corroborate our experimental work. We document significantly increased levels of NET complexes and extracellular histones bearing classic NET-associated posttranslational modifications, in blood and local lesions of severe periodontitis patients, in the absence of confounding disease. Our findings suggest a feed-forward loop in which NETs trigger IL-17 immunity to promote immunopathology in a prevalent human inflammatory disease.

24 November 2003 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
KLKarin List
Karin List
RSRoman Szabo
Roman Szabo
PWPhilip W. Wertz
Philip W. Wertz
JSJulie Segre
Julie Segre
CHChristian C. Haudenschild
Christian C. Haudenschild
TBThomas Bugge
Thomas Bugge
Profilaggrin is a large epidermal polyprotein that is proteolytically processed during keratinocyte differentiation to release multiple filaggrin monomer units as well as a calcium-binding regulatory NH2-terminal filaggrin S-100 protein. We show that epidermal deficiency of the transmembrane serine protease Matriptase/MT-SP1 perturbs lipid matrix formation, cornified envelope morphogenesis, and stratum corneum desquamation. Surprisingly, proteomic analysis of Matriptase/MT-SP1–deficient epidermis revealed the selective loss of both proteolytically processed filaggrin monomer units and the NH2-terminal filaggrin S-100 regulatory protein. This was associated with a profound accumulation of profilaggrin and aberrant profilaggrin-processing products in the stratum corneum. The data identify keratinocyte Matriptase/MT-SP1 as an essential component of the profilaggrin-processing pathway and a key regulator of terminal epidermal differentiation.